APM
Avidity Partners Management’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Buy |
1,064,500
+264,500
| +33% | +$2.54M | 2.03% | 16 |
|
|
2025
Q1 | $5.02M | Sell |
800,000
-590,100
| -42% | -$3.7M | 0.96% | 35 |
|
|
2024
Q4 | $11.3M | Sell |
1,390,100
-414,393
| -23% | -$3.36M | 1.11% | 36 |
|
|
2024
Q3 | $32.6M | Buy |
1,804,493
+184,493
| +11% | +$3.34M | 1.66% | 24 |
|
|
2024
Q2 | $16.7M | Sell |
1,620,000
-115,000
| -7% | -$1.18M | 0.71% | 51 |
|
|
2024
Q1 | $18.4M | Buy |
1,735,000
+13,420
| +0.8% | +$143K | 0.59% | 51 |
|
|
2023
Q4 | $15.7M | Buy |
1,721,580
+104,280
| +6% | +$952K | 0.57% | 49 |
|
|
2023
Q3 | $16.8M | Sell |
1,617,300
-332,400
| -17% | -$3.45M | 0.68% | 55 |
|
|
2023
Q2 | $27.9M | Sell |
1,949,700
-98,900
| -5% | -$1.42M | 0.98% | 42 |
|
|
2023
Q1 | $14.6M | Buy |
2,048,600
+148,600
| +8% | +$1.06M | 0.49% | 61 |
|
|
2022
Q4 | $21.3M | Sell |
1,900,000
-6,800
| -0.4% | -$76.3K | 0.46% | 49 |
|
|
2022
Q3 | $21.1M | Sell |
1,906,800
-13,000
| -0.7% | -$144K | 0.43% | 51 |
|
|
2022
Q2 | $16.2M | Sell |
1,919,800
-26,200
| -1% | -$221K | 0.37% | 41 |
|
|
2022
Q1 | $26.5M | Buy |
1,946,000
+50,000
| +3% | +$680K | 0.55% | 45 |
|
|
2021
Q4 | $37.3M | Buy |
+1,896,000
| New | +$37.3M | 0.79% | 42 |
|
|
2021
Q1 | – | Sell |
-152,500
| Closed | -$5.07M | – | 117 |
|
|
2020
Q4 | $5.07M | Buy |
+152,500
| New | +$5.07M | 0.16% | 79 |
|